ESSENER BOGEN 7, HAMBURG, 2M
Notification of Major Holdings
Announces Preliminary Nine-Months 2026 Results Above Market Expectations, Reaffirming Full-Year 2026 Guidance
Announces Chief Scientific Officer Transition
Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
Announces Second Quarter and First Half 2026 Results: Growing Commercial Momentum
Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Announces Directors’ Dealing of Cord Dohrmann
Announces First Quarter 2026 Results: Building Transformation Momentum
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Certificate
Registration of Securities
Amended Registration Statement for Securities of Certain Foreign Private Issuers
No filings found
Amended Schedule 13D - Ownership Report
Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
NT 20-F
SEC Staff Correspondence
Correspondence
Submission Upload